These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-001199-37 A Phase II, Single Arm, Open label Study of Cyclophosphamide, Vincristine, Liposomal Doxorubicine (Myocet™) and Prednisone plus Rituximab in Fortnightly Regimen (R-COMP-14), as First Line of therapy ... not-yet-due
Completed, but no date 2007-003091-19 "Tratamiento de consolidación con Y90-Ibritumomab Tiuxetan en Pacientes con Linfoma Folicular de Alto Riesgo, en respuesta parcial o completa a Quimioterapia de Inducción con R-CHOP" bad-data
Ongoing 2008-007650-35 Estudio Fase II abierto prospectivo no aleatorizado para valorar la combinación de rituximab, bendamustina (R-B) en pacientes con Linfoma Folicular refractarios o en recaída tras tratamiento con R-qu... not-yet-due
Ongoing 2009-016588-12 ENSAYO FASE II PARA VALORAR LA COMBINACIÓN DE LENALIDOMIDA CON DOSIS METRONÓMICAS DE CICLOFOSFAMIDA EN PACIENTES CON LINFOMA DE HODGKIN CLÁSICO REFRACTARIO O EN RECAÍDA not-yet-due
Ongoing 2014-001620-29 Phase II clinical trial to evaluate the combination of lenalidomide with R-GDP (rituximab, gemcitabine, dexamethasone and cisplatin) in patients diagnosed with refractory diffuse large B-cell lymphoma... not-yet-due